Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough

This publication has 13 references indexed in Scilit:

• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
  Published by Elsevier ,2006
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
  Annals of Internal Medicine, 2006
• A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users
  Harm Reduction Journal, 2006
• Persistent HIV Incidence Among Injection Drug Users in San Francisco During the 1990s: Results of Five Studies
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
• Global Burden of Disease (GBD) for Hepatitis C
  The Journal of Clinical Pharmacology, 2004
• The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users
  International Journal of Epidemiology, 2003
• Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks
  The Journal of Infectious Diseases, 2002
• Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San Francisco
  Hepatology, 2001
• Effectiveness of needle-exchange programmes for prevention of HIV infection
  The Lancet, 1997
• Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
  American Journal of Public Health, 1996